4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-14-069943
Options or other derivatives
- Chief Technology Officer acquired 28,140 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
GRAZIANO JAMES JOSEPH · Chief Technology Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2014-11-18 | Grant or award : show line 1 in the form Common Stock Option (right to buy) | +28,140 | 28,140 | D |
Loading xslF345X03/form471632_20141120093121-.xml…